miR-21 is known to promote cell proliferation [7] and initiate inflammation-associated carcinogenesis via nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and interleukin-6 (IL-6) signaling pathways in colon and cervical cancer cells [20, 21]. This evidence concerns the gene IL6 and cervical carcinoma.